Mink Book Value Per Share from 2010 to 2024

INKT Stock

USD 0.69 0.01 1.43%

Mink Therapeutics Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share will likely drop to -0.55 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Mink Therapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

(0.53)

Current Value

(0.55)

Quarterly Volatility

0.57006334

Credit Downgrade

Yuan Drop

Covid

Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 584.4 K, Depreciation And Amortization of 118.7 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 0.0355, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.

Check out the analysis of Mink Therapeutics Correlation against competitors.

For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Latest Mink Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Mink Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Mink Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mink Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (0.52) X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Mink Book Value Per Share Regression Statistics

	Arithmetic Mean	(0.87)
	Geometric Mean	0.74
	Coefficient Of Variation	(65.84)
	Mean Deviation	0.41
	Median	(1.10)
	Standard Deviation	0.57
	Sample Variance	0.32
	Range	2.3385
	R-Value	0.51
	Mean Square Error	0.26
	R-Squared	0.26
	Significance	0.05
	Slope	0.07
	Total Sum of Squares	4.55

Mink Book Value Per Share History

	2024	-0.55
	2023	-0.53
	2022	-0.0119
	2021	0.71
	2020	-1.63

Other Fundumenentals of Mink Therapeutics

Tangible Book Value Per Share

Mink Therapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Surpluse
Total Assets		0.91	0.79	0.05	-0.87	-0.45	0.45	0.59	-0.61	-0.64	0.91	1.0	0.67	0.97	0.05	0.67	0.4	0.05
Total Stockholder Equity	0.91		0.96	-0.2	-0.99	-0.63	0.54	0.57	-0.59	-0.9	0.74	0.9	0.83	0.91	-0.2	0.83	0.57	-0.2
Net Tangible Assets	0.79	0.96		-0.47	-0.98	-0.8	0.61	0.67	-0.69	-0.93	0.53	0.78	0.93	0.76	-0.47	0.93	0.7	-0.47
Current Deferred Revenue	0.05	-0.2	-0.47		0.34	0.75	-0.41	-0.44	0.53	0.4	0.39	0.07	-0.59	0.16	1.0	-0.59	-0.49	1.0
Net Debt	-0.87	-0.99	-0.98	0.34		0.75	-0.65	-0.67	0.69	0.91	-0.63	-0.86	-0.91	-0.84	0.34	-0.91	-0.68	0.34
Retained Earnings	-0.45	-0.63	-0.8	0.75	0.75		-0.83	-0.86	0.87	0.68	-0.03	-0.43	-0.96	-0.31	0.75	-0.96	-0.91	0.75
Accounts Payable	0.45	0.54	0.61	-0.41	-0.65	-0.83		0.75	-0.78	-0.52	0.09	0.44	0.81	0.34	-0.41	0.81	0.85	-0.41
Long Term Debt	0.59	0.57	0.67	-0.44	-0.67	-0.86	0.75		-0.97	-0.43	0.23	0.57	0.85	0.41	-0.44	0.85	0.84	-0.44
Net Receivables	-0.61	-0.59	-0.69	0.53	0.69	0.87	-0.78	-0.97		0.43	-0.26	-0.6	-0.85	-0.43	0.53	-0.85	-0.76	0.53
Total Liab	-0.64	-0.9	-0.93	0.4	0.91	0.68	-0.52	-0.43	0.43		-0.42	-0.63	-0.82	-0.67	0.4	-0.82	-0.65	0.4
Net Invested Capital	0.91	0.74	0.53	0.39	-0.63	-0.03	0.09	0.23	-0.26	-0.42		0.91	0.3	0.95	0.39	0.3	0.01	0.39
Total Current Assets	1.0	0.9	0.78	0.07	-0.86	-0.43	0.44	0.57	-0.6	-0.63	0.91		0.65	0.98	0.07	0.65	0.38	0.07
Capital Stock	0.67	0.83	0.93	-0.59	-0.91	-0.96	0.81	0.85	-0.85	-0.82	0.3	0.65		0.57	-0.59	1.0	0.89	-0.59
Net Working Capital	0.97	0.91	0.76	0.16	-0.84	-0.31	0.34	0.41	-0.43	-0.67	0.95	0.98	0.57		0.16	0.57	0.29	0.16
Short Term Debt	0.05	-0.2	-0.47	1.0	0.34	0.75	-0.41	-0.44	0.53	0.4	0.39	0.07	-0.59	0.16		-0.59	-0.49	1.0
Common Stock	0.67	0.83	0.93	-0.59	-0.91	-0.96	0.81	0.85	-0.85	-0.82	0.3	0.65	1.0	0.57	-0.59		0.89	-0.59
Property Plant Equipment	0.4	0.57	0.7	-0.49	-0.68	-0.91	0.85	0.84	-0.76	-0.65	0.01	0.38	0.89	0.29	-0.49	0.89		-0.49
Capital Surpluse	0.05	-0.2	-0.47	1.0	0.34	0.75	-0.41	-0.44	0.53	0.4	0.39	0.07	-0.59	0.16	1.0	-0.59	-0.49

Click cells to compare fundamentals

About Mink Therapeutics Financial Statements

Mink Therapeutics shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	(0.53)	(0.55)
Tangible Book Value Per Share	(0.53)	(0.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC